FDA Grants Priority Review to Sarclisa for Multiple Myeloma

7 months ago 36

Sarclisa was granted a priority review by the Food and Drug Administration for patients newly diagnosed with multiple myeloma who are ineligible for blood transplants.

View Entire Post

Read Entire Article